Underreported: The Stories You Missed in 2011

Thursday, December 01, 2011

On this week’s Underreported, Foreign Policy’s Joshua Keating discusses “The Stories You Missed in 2011,” including India’s military buildup and the shrinking supply of camel meat in Saudi Arabia.


Joshua Keating

Comments [1]

Ed from Larchmont

Geron Corp. is exiting the field it pioneered in a calculated business move that underscores the long, costly path embryonic stem cells face to become real-world products.

Late Monday, the company said it would halt its study of a stem cell-based treatment for spinal cord injury, the first embryonic stem cell trial approved in the U.S.

The Menlo Park, Calif., company had long been viewed as the undisputed leader in stem cell therapies.

Dec. 01 2011 08:24 AM

Leave a Comment

Email addresses are required but never displayed.

Get the WNYC Morning Brief in your inbox.
We'll send you our top 5 stories every day, plus breaking news and weather.